Genetic Susceptibility and Immunological Synapse in Type 1 Diabetes and Thyroid Autoimmune Disease[1]

 

 Buy Article Permissions and Reprints

Abstract

Type 1 diabetes mellitus results from an immune mediated or idiopathic destruction of the pancreatic beta cells. Its aetiopathogenesis remains to be elucidated, despite great progress in the characterisation of beta-cell antigens, T-lymphocyte and antibody markers as well as whole genome screening. The incidence of type 1 diabetes is rising in most countries. Moreover, a considerable proportion of patients initially presenting with type 2 diabetes mellitus have an underlying type 1 diabetes with a latent course. A proportion of type 1 diabetes patients have concomittant thyroid autoimmune disease, either Hashimoto's thyroiditis or Graves' disease. Whereas Hashimoto's thyroiditis shares the same destructive immune process as type 1 diabetes, Graves' disease is unique in stimulating specifically the TSH-receptor through high-affinity immunoglobulins. However, both the thyroid autoimmune disorders and type 1 diabetes have susceptibility genes in common, implying shared pathways of immunopathogenesis. It has become clear that the genetic composition of a host at least partly determines the course of an immune response leading either to an organ-specific autoimmune disease or creating a state of balance where antibodies are hallmarks of (auto)immunity but normal function prevails. Genetic factors including MHC (IDDM 1-genetic locus) and non-MHC genes (IDDM 2 - IDDM X) have been shown to determine susceptibility to autoimmunity in type 1 diabetes or lifelong tolerance. Currently the importance of the various diabetes associated genes is becoming clearer due to functional studies. Our review attempts to compile the relevant data that have accumulated in recent years and offers perspectives for prediction, prevention and possibly even therapy of immune-mediated endocrinopathies.

1 This review is decicated to Klaus H. Usadel on the occasion of his 65th birthday.

References

• 1 Arif S, Tree T I, Astill T P, Tremble J M, Bishop A J, Dayan C M, Roep B O, Peakman M. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.  J Clin Invest. 2004;  113 451-463
  CrossrefPubMedGoogle Scholar
• 2 Baur M P, Fimmers R, Fritsche C, Hümmelink M, Neugebauer M, Acton R T, Hodge T, Barbosa J, Bertrams J, Fehsel K, Kolb H, Rothe H, Boehm B, Cambon-Thomsen A, Avoustin P, Coppin H, Darnaud J, Massabie P, Ohayon E, De Preval C, Tauber J P, Thomsen M, Colle E, MacDonald M J, Nevin D, Gottschall H, Nepom G T, Robinson D M, Holbeck S, Palmer J P, Nerup J, Rotter J I, Vadheim C, Rittner C, Schneider P, Sheehy M J, Cox N J, Baker L, Spielman R S. Genetic analysis of IDDM: The GAW5 multiplex family dataset.  Genetic Epidemiology. 1989;  6 15-20
  CrossrefPubMedGoogle Scholar
• 3 Bennett S T, Lucassen A M, Gough S CL, Powell E E, Undlien D E, Pritchard L E, Merriman M E, Kawaguchi Y, Dronsfield M J, Pociot F, Nerup J, Bouzekri N, Cambon-Thomsen A, Ronningen K S, Barnett A H, Bain S C, Todd J A. Susceptibility to human type 1 diabetes at IDDM 2 is determined by tandem repeat variation at the insulin gene minisatellite locus.  Nature Genetics. 1995;  9 284-292
  CrossrefPubMedGoogle Scholar
• 4 Boehm B O, Manfras B, Seissler J, Schoeffling K, Glueck M, Holzberger G, Seidl S, Kuehnl P, Trucco M, Scherbaum W A. Epidemiology and immunogenetic background of islet cell antibody-positive nondiabetic schoolchildren: Ulm-Frankfurt population study.  Diabetes. 1991 a;  40 1435-1439
  PubMedGoogle Scholar
• 5 Boehm B O, Seißler J, Glueck M, Manfras B J, Thomas H, Schmidt K, Rudert W A, Usadel K H, Trucco M, Scherbaum W A. The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQβ chain.  Dis Markers. 1991 b;  9 273-280
  PubMedGoogle Scholar
• 6 Braun J, Donner H, Siegmund T, Walfish P G, Usadel K H, Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.  Tissue Antigens. 1998;  51 563-566
  PubMedGoogle Scholar
• 7 Bromley S K, Burack W R, Johnson K G, Somersalo K, Sims T N, Sumen C, Davis M M, Shaw A S, Allen P M, Dustin M L. The immunological synapse.  Annu Rev Immunol. 2001;  19 375-396
  CrossrefPubMedGoogle Scholar
• 8 Concannon P, Gogolin-Ewens K J, Hinds D A, Wapelhorst B, Morrison V A, Stirling B, Mitra M, Farmer J, Williams S R, Cox N J, Bell G I, Risch N, Spielman R S. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus.  Nature Genetics. 1998;  19 292-296
  PubMedGoogle Scholar
• 9 Corper A L, Stratmann T, Apostolopoulos V, Scott C A, Garcia K C, Kang A S, Wilson I A, Teyton L. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.  Science. 2000;  288 505-511
  CrossrefPubMedGoogle Scholar
• 10 Cox N J, Wapelhorst B, Morrison V A, Johnson L, Pinchuk L, Spielman R S, Todd J A, Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.  Am J Hum Genet. 2001;  69 820-830
  CrossrefPubMedGoogle Scholar
• 11 Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain S C, Barnett A H, Todd J A. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins.  Hum Mol Genet. 2001;  10 2025-2037
  CrossrefPubMedGoogle Scholar
• 12 Cudworth A G, Woodrow J C. Evidence for HL-A-linked genes in “juvenile” diabetes mellitus.  Br Med J. 1975;  3 133-135
  PubMedGoogle Scholar
• 13 Curtsinger J M, Schmidt C S, Mondino A, Lins D C, Kedl R M, Jenkins M K, Mescher M F. Inflammatory cytokines provide a third signal for activation of naive CD4 + and CD8 + T cells.  J Immunol. 1999;  162 3256-3262
  PubMedGoogle Scholar
• 14 Davies J L, Kawaguchi Y, Bennett S T, Copeman J B, Cordell H J, Pritchard L E, Reed P W, Gough S CL, Jenkins S C, Palmer S M, Balfour K M, Rowe B R, Farrall M, Barnett A H, Bain S C, Todd J A. A genome-wide search for human type 1 diabetes susceptibility genes.  Nature. 1994;  371 130-136
  CrossrefPubMedGoogle Scholar
• 15 De Oliveira D B, Harfouch-Hammoud E, Otto H, Papandreou N A, Stern L J, Cohen H, Boehm B O, Bach J, Caillat-Zucman S, Walk T, Jung G, Eliopoulos E, Papadopoulos G K, van Endert P M. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.  Mol Immunol. 2000;  37 813-825
  CrossrefPubMedGoogle Scholar
• 16 Delon J, Germain R N. Information transfer at the immunological synapse.  Curr Biol. 2000;  10 R923-933
  CrossrefPubMedGoogle Scholar
• 17 Demotz S, Grey H M, Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation.  Science. 1990;  249 1028-1030
  PubMedGoogle Scholar
• 18 Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.  Nat Med. 1999;  5 1365-1369
  PubMedGoogle Scholar
• 19 Donner H, Braun J, Seidl C, Rau H, Finke R, Ventz M, Walfish P G, Usadel K H, Badenhoop K. Codon 17 polymorphism of the CTLA4 gene in Hashimoto's thyroiditis and Addison's disease.  J Clin Endocrino Metab. 1997 a;  82 4130-4132
  PubMedGoogle Scholar
• 20 Donner H, Rau H, Walfish P G, Braun J, Siegmund T, Finke R, Usadel K H, Badenhoop K. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.  J Clin Endocrinol Metab. 1997 b;  82 143-146
  CrossrefPubMedGoogle Scholar
• 21 Durinovic-Bello I, Riedl M, Rosinger S, Maisel N, Kalbacher H, Deeg M, Neckermann J, Schreckling H-J, Schlosser M, Ziegler M, Kuehnl P, Boehm B O. Th2 dominance of T helper cell response to preproinsulin in individuals with preclinical type 1 diabetes.  Annals New York Academy Sciences. 2002 a;  958 209-213
  PubMedGoogle Scholar
• 22 Durinovic-Bello I, Boehm B O, Ziegler A-G. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity.  J Autoimmunity. 2002 b;  18 55-66
  CrossrefPubMedGoogle Scholar
• 23 Durinovic-Bello I, Maisel N, Schlosser M, Kalbacher H, Deeg M, Eiermann T, Karges W, Boehm B O. Relationship between T and B cell responses to proinsulin in human type 1 diabetes.  Ann NY Acad Sci USA. 2003;  1005 288-294
  PubMedGoogle Scholar
• 24 Durinovic-Bello I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliot J, Roep B O, Boehm B O. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.  Diabetologia. 2004;  47 439-450
  CrossrefPubMedGoogle Scholar
• 25 Fimmers R, Neugebauer M, Dennert J, Wienker T, Baur M P. Association and sibpair analysis for the HLA, Gm, Km, and insulin polymorphisms in multiplex IDDM families.  Genetic Epidemiology. 1989;  6 107-112
  CrossrefPubMedGoogle Scholar
• 26 French M B, Allison J, Cram D S, Thomas H E, Dempsey-Collier M, Silva A, Georgiou H M, Kay T W, Harrison L C, Lew A M. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.  Diabetes. 1997;  46 34-39
  CrossrefPubMedGoogle Scholar
• 27 Gao W, Demirci G, Li X C. Negative T cell costimulation and islet tolerance.  Diabetes Metab Res Rev. 2003;  19 179-185
  CrossrefPubMedGoogle Scholar
• 28 Gorsuch A N, Spencer K M, Lister J, Wolf E, Bottazzo G F, Cudworth A G. Can future type I diabetes be predicted? A study in families of affected children.  Diabetes. 1982;  31 862-866
  PubMedGoogle Scholar
• 29 Grakoui A, Bromley S K, Sumen C, Davis M M, Shaw A S, Allen P M, Dustin M L. The immunological synapse: a molecular machine controlling T cell activation.  Science. 1999;  285 221-227
  CrossrefPubMedGoogle Scholar
• 30 Guerkov R EM, Targoni O S, Kreher C R, Boehm B O, Herrera M T, Tary-Lehmann M, Lehmann P V, Schwander S K. Detection of low frequency antigen-specific IL-10-producing CD4 + T cells via ELISPOT in PBMC: Cognate vs. non-specific production of the cytokine.  J Immunol Methods. 2003;  279 111-121
  CrossrefPubMedGoogle Scholar
• 31 Harding C V, Unanue E R. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.  Nature. 1990;  346 574-576
  CrossrefPubMedGoogle Scholar
• 32 Hashimoto L, Habita C, Beressi J P, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter J I, Djoulah S, James M R, Froguel P, Weissenbach J, Lathrop G M, Julier C. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11 q.  Nature. 1994;  371 161-164
  CrossrefPubMedGoogle Scholar
• 33 Hesse M D, Karulin A Y, Boehm B O, Lehmann P V, Tary-Lehmann M. A T-cell clone's avidity is a function of its activation state.  J Immunol. 2001;  167 1353-1361
  PubMedGoogle Scholar
• 34 Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells.  Immunity. 1998;  8 89-95
  CrossrefPubMedGoogle Scholar
• 35 Jury K M, Loeffler D, Eiermann T H, Ziegler B, Boehm B O, Richter W. Evidence for somatic mutation and affinity maturation of diabetes associated human autoantibodies to glutamate decarboxylase.  J Autoimmun. 1996;  9 371-377
  CrossrefPubMedGoogle Scholar
• 36 Karges W, Pechhold K, Al Dahouk S, Riegger I, Rief M, Wissmann A, Schirmbeck R, Barth C, Boehm B O. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in NOD and in RIP-B7. 1 mice.  Diabetes. 2002;  51 3237-3244
  PubMedGoogle Scholar
• 37 Karges B, Durinovic-Bello I, Heinze E, Boehm B O, Debatin K-M, Karges W. Complete long-term recovery of beta cell function in autoimmune Type 1 diabetes following insulin treatment.  Diabetes Care. 2004;  27 1207-1208
  PubMedGoogle Scholar
• 38 Katz J D, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis.  Cell. 1993;  74 1089-1100
  CrossrefPubMedGoogle Scholar
• 39 Klehmet J, Shive C, Guardia-Wolff R, Petersen I, Spack E G, Boehm B O, Weissert R, Forsthuber T G. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.  Clin Immunol. 2004;  111 53-60
  CrossrefPubMedGoogle Scholar
• 40 Kolb H. .  Benign versus destructive insulitis Diabetes Metab Rev. 1997;  13 139-146
  PubMed
• 41 Kreher C R, Dittrich M T, Guerkov R, Boehm B O, Tary-Lehmann M. CD4 + and CD8 + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISA assays.  J Immunol Methods. 2003;  278 79-93
  CrossrefPubMedGoogle Scholar
• 42 Kremer J M, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah I F, Williams G R, Becker J C, Hagerty D T, Moreland L W. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.  N Engl J Med. 2003;  349 1907-1915
  CrossrefPubMedGoogle Scholar
• 43 Lampeter E F, Homberg M, Quabeck K, Schaefer U W, Wernet P, Bertrams J, Grosse-Wilde H, Gries F A, Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation.  Lancet. 1993;  341 1243-1244
  CrossrefPubMedGoogle Scholar
• 44 Lee K H, Wucherpfennig K W, Wiley D C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.  Nat Immunol. 2001;  2 501-507
  CrossrefPubMedGoogle Scholar
• 45 Lee K H, Holdorf A D, Dustin M L, Chan A C, Allen P M, Shaw A S. T cell receptor signaling precedes immunological synapse formation.  Science. 2002;  295 1539-1542
  CrossrefPubMedGoogle Scholar
• 46 Lehmann P V, Sercarz E E, Forsthuber T, Dayan C M, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire.  Immunol Today. 1993;  14 203-208
  CrossrefPubMedGoogle Scholar
• 47 Li H, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.  J Clin Endocrinol Metabolism. 2001;  86 574-582
  PubMedGoogle Scholar
• 48 Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum W A, Kolb H, Noordzij J G, Roep B O. Development of type 1 diabetes despite severe hereditary B-cell deficiency.  N Engl J Med. 2001;  345 1036-1040
  CrossrefPubMedGoogle Scholar
• 49 McDevitt H. Closing in on Type 1 diabetes.  N Engl J Med. 2001;  345 1060-1061
  CrossrefPubMedGoogle Scholar
• 50 Mein C A, Esposito L, Dunn M G, Johnson G CL, Timms A E, Goy J V, Smith A N, Sebag-Montefiore L, Merriman M E, Wilson A J, Pritchard L E, Cucca F, Barnett A H, Bain S C, Todd J A. A search for type 1 diabetes susceptibility genes in families from the United Kingdom.  Nature Genetics. 1998;  19 297-300
  CrossrefPubMedGoogle Scholar
• 51 Morel P A, Dorman J S, Todd J A, McDevitt H O, Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.  Proc Natl Acad Sci USA. 1988;  86 8111-8115
  PubMedGoogle Scholar
• 52 Nerup J, Platz P, Andersen O O, Christy M, Lyngsoe J, Poulsen J E, Ryder L P, Nielsen L S, Thomsen M, Svejgaard A. HLA antigens and diabetes mellitus.  Lancet. 1974;  2 864-866
  PubMedGoogle Scholar
• 53 Ott P A, Dittrich M T, Herzog B A, Guerkov R, Gottlieb P A, Putnam A L, Durinovic-Bello I, Boehm B O, Tary-Lehmann M, Lehmann P V. T-cells recognize multiple GAD65 and proinsulin epitopes in human Type 1 diabetes, suggesting determinant spreading.  J Clin Immunol. 2004;  24 327-339
  CrossrefPubMedGoogle Scholar
• 54 Pani M A, Van Autreve J, Van Der Auwera B J, Gorus F K, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of Type I diabetes in offspring: the importance of foetal or post partum exposure to diabetogenic molecules.  Diabetologia. 2002;  45 1340-1343
  CrossrefPubMedGoogle Scholar
• 55 Peakman M, Tree T I, Endl J, van Endert P, Atkinson M A, Roep B O. Second International Immunology of Diabetes Society Workshop for Standardization of T-Cell Assays in Type 1 Diabetes. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-Cell Assays in Type 1 Diabetes.  Diabetes. 2001;  50 1749-1754
  PubMedGoogle Scholar
• 56 Pechhold K, Patterson N B, Blum C, Fleischacker C L, Boehm B O, Haralan D M. Low dose streptozotocin induced diabetes in rat insulin promotor (RIP)-mCD80 transgenic mice is T cell autoantigen-specific and CD28 dependent.  J Immunol. 2001;  166 2531-2539
  PubMedGoogle Scholar
• 57 Pechhold K, Karges W, Boehm B O, Harlan D M. Beta cell-specific CD80 (B7 - 1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes.  J Autoimmun. 2003;  20 1-13
  CrossrefPubMedGoogle Scholar
• 58 Pociot F, Karlsen A E, Pedersen C B, Aalund M, Nerup J. Novel analytical methods applied to type 1 diabetes genome-scan data.  Am J Hum Genet. 2004;  74 647-660
  CrossrefPubMedGoogle Scholar
• 59 Pociot F, McDermott M F. Genetics of type 1 diabetes mellitus.  Genes Immu. 2002;  3 235-249
  PubMedGoogle Scholar
• 60 Pugliese A, Zeller M, Fernandez Jr A, Zalcberg L J, Bartlett R J, Ricordi C, Pietropaolo M, Eisenbarth G S, Bennett S T, Dhavalkumar D P. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM 2 susceptibility locus for type 1 diabetes.  Nature Genetics. 1997;  15 293-297
  CrossrefPubMedGoogle Scholar
• 61 Reay P A, Matsui K, Haase K, Wülfing C, Chien Y H, Davis M M. Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies.  J Immunol. 2000;  164 5626-5632
  PubMedGoogle Scholar
• 62 Richter W, Mertens T, Schoel B, Muir P, Ritzkowsky A, Scherbaum W A, Boehm B O. Sequence homology of the diabetes associated autoantigen glutamate decarboxylase with coxsackie B4 - 2 C protein and heat shock protein 60 mediates no molecular mimikry of autoantibodies.  J Exp Med. 1994;  180 721-726
  CrossrefPubMedGoogle Scholar
• 63 Richter W, Jury K M, Loeffler D, Manfras B J, Eiermann T H, Boehm B O. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen driven immune response to glutamic acid decarboxylase in type I diabetes mellitus.  Eur J Immunol. 1995;  25 1703-1712
  PubMedGoogle Scholar
• 64 Rininsland F H, Helms T, Asaad R J, Boehm B O, Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity.  J Immunol Method. 2000;  240 143-155
  CrossrefPubMedGoogle Scholar
• 65 Rothe H, Jenkins N A, Copeland N G, Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.  J Clin Invest. 1997;  99 469-74
  PubMedGoogle Scholar
• 66 Salomon B, Bluestone J A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.  Annu Rev Immunol. 2001;  19 225-252
  CrossrefPubMedGoogle Scholar
• 67 Seidl C, Donner H, Fischer B, Usadel K H, Seifried E, Kaltwasser P, Badenhoop K. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis.  Tissue Antigens. 1998;  51 62-66
  PubMedGoogle Scholar
• 68 Shahinian A, Pfeffer K, Lee K P, Kundig T M, Kishihara K, Wakeham A, Kawai K, Ohashi P S, Thompson C B, Mak T W. Differential T cell costimulatory requirements in CD28-deficient mice.  Science. 1993;  261 609-612
  PubMedGoogle Scholar
• 69 Targoni O S, Baus J, Hofstetter H H, Hesse M D, Karulin A Y, Boehm B O, Forsthuber T G, Lehmann P V. Frequencies of neuroantigen-specific T cells in the central nervous system the immune periphery during the course of experimental allergic encephalomyelitis.  J Immunol. 2001;  166 4757-4764
  PubMedGoogle Scholar
• 70 Todd J A, Wicker L S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models.  Immunity. 2001;  15 387-395
  CrossrefPubMedGoogle Scholar
• 71 Trowsdale J, Parham P. Mini-review: defense strategies and immunity-related genes.  Eur J Immunol. 2004;  34 7-17
  CrossrefPubMedGoogle Scholar
• 72 Ueda H, Howson J M, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow D B, Hunter K M, Smith A N, Di Genova G, Herr M H, Dahlman I, Payne F, Smyth D, Lowe C, Twells R C, Howlett S, Healy B, Nutland S, Rance H E, Everett V, Smink L J, Lam A C, Cordell H J, Walker N M, Bordin C, Hulme J, Motzo C, Cucca F, Hess J F, Metzker M L, Rogers J, Gregory S, Allahabadia A, Nithiyananthan R, Tuomilehto-Wolf E, Tuomilehto J, Bingley P, Gillespie K M, Undlien D E, Ronningen K S, Guja C, Ionescu-Tirgoviste C, Savage D A, Maxwell A P, Carson D J, Patterson C C, Franklyn J A, Clayton D G, Peterson L B, Wicker L S, Todd J A, Gough S C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.  Nature. 2003;  423 506-511
  Google Scholar
• 73 Unanue E R. Antigen-presenting function of the macrophage.  Annu Rev Immunol. 1984;  2 395-428
  CrossrefPubMedGoogle Scholar
• 74 Waldner H, Collins M, Kuchroo V K. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease.  J Clin Invest. 2004;  113 990-997
  CrossrefPubMedGoogle Scholar
• 75 Wicker L S, Miller B J, Chai A, Terada M, Mullen Y. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells: transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.  J Exp Med. 1988;  167 1801-1810
  CrossrefPubMedGoogle Scholar
• 76 Williams C B, Engle D L, Kersh G J, Michael White J, Allen P M. A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex.  J Exp Med. 1999;  189 1531-1544
  CrossrefPubMedGoogle Scholar
• 77 Yang M, Charlton B, Gautam A M. Development of insulitis and diabetes in B cell-deficient NOD mice.  J Autoimmun. 1997;  10 257-260
  CrossrefPubMedGoogle Scholar
• 78 Zavattari P, Lampis R, Mulargia A, Loddo M, Angius E, Todd J A, Cucca F. Confirmation of the DRB1-DQB1 loci as the major component of IDDM 1 in the isolated founder population of Sardinia.  Human Molecular Genetics. 2000;  9 2967-2972
  CrossrefPubMedGoogle Scholar
• 79 Zerbib A, Molvig J, Thomsen M, Coppin H, Cambon-Thomsen A, Sommer E, Nerup J, De Préval C. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.  Disease Markers. 1989;  7 27-41
  PubMedGoogle Scholar

1 This review is decicated to Klaus H. Usadel on the occasion of his 65th birthday.

M. D. Bernhard O. Boehm

Sektion Endokrinologie
Abteilung Innere Medizin I
Universität Ulm

Robert-Koch-Straße 8

89070 Ulm

Germany

Phone: + 4973150023404

Fax: + 49 7 31 50 02 39 38

Email: bernhard.boehm@medizin.uni-ulm.de